Home > Insider Trading > Filing (0001354488-13-002276)

Filing Details

Accession Number:: 0001354488-13-002276
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-29 13:25:55
Reporting Period:: 2003-05-23

Filing Date:: 2013-04-29
Accepted Time:: 2013-04-29 13:25:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
834365	Biolife Solutions Inc	BLFS	Electromedical & Electrotherapeutic Apparatus (3845)	943076866

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1113655	Walter Villiger	Paradiesstrasse 25 Ch 8645 Jona V8 00000		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Acquisiton	2005-12-31	2,360,474	$0.12	2,760,474	No	4	P	Direct
Common Shares	Acquisiton	2006-05-01	2,000,000	$0.00	4,760,474	No	4	C	Direct
Common Shares	Acquisiton	2006-05-01	5,625,000	$0.00	10,385,474	No	4	C	Direct
Common Shares	Acquisiton	2006-05-01	1,000,000	$0.04	11,385,474	No	4	X	Direct
Common Shares	Acquisiton	2006-05-01	5,625,000	$0.04	17,010,474	No	4	X	Direct
Common Shares	Acquisiton	2006-05-01	750,000	$0.04	17,760,474	No	4	X	Direct
Common Shares	Acquisiton	2006-05-01	1,062,941	$0.06	18,823,415	No	4	P	Direct
Common Shares	Acquisiton	2007-02-13	416,666	$0.00	19,240,081	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	C	Direct
No	4	C	Direct
No	4	X	Direct
No	4	X	Direct
No	4	X	Direct
No	4	P	Direct
No	4	J	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Share Warrants	Acquisiton	2003-05-23	750,000	$0.00	750,000	$0.08
Common Stock	Common Share Warrants	Disposition	2006-05-01	750,000	$0.00	750,000	$0.04
Common Stock	Series F Preferred Shares	Disposition	2006-05-01	5,000	$200.01	2,000,000	$0.00
Common Stock	Series F Preferred Warrants	Disposition	2006-05-01	2,500	$200.01	1,000,000	$0.04
Common Stock	Series G Preferred Shares	Disposition	2006-05-01	18	$25,000.00	5,625,000	$0.00
Common Stock	Series G Preferred Warrants	Disposition	2006-05-01	18	$25,000.00	5,625,000	$0.04
Common Shares	Common Share Warrants	Acquisiton	2010-11-29	1,000,000	$0.00	1,000,000	$0.07
Common Shares	Common Share Warrants	Acquisiton	2011-08-10	1,000,000	$0.00	1,000,000	$0.06
Common Shares	Common Share Warrants	Acquisiton	2012-05-30	1,000,000	$0.00	1,000,000	$0.08

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
750,000	2003-05-23	2008-05-23	No	4	J	Direct
0	2003-05-23	2008-05-23	No	4	X	Direct
0	2001-12-31		No	4	C	Direct
0	2001-12-31	2006-10-31	No	4	X	Direct
0	2004-01-13		No	4	C	Direct
0	2004-01-13	2013-10-31	No	4	X	Direct
1,000,000	2010-11-29	2015-11-29	No	4	J	Direct
1,000,000	2011-08-10	2016-08-30	No	4	J	Direct
1,000,000	2012-05-30	2017-05-30	No	4	J	Direct

Footnotes

On May 23, 2003, the reporting person acquired 750,000 common share purchase warrants from the issuer in connection with the issuance of a 12-month promissory note evidencing a loan from the reporting person to the Issuer.
Resulting purchase from cash dividends paid to Series G preferred stockholders; purchase price based on December 31, 2005 closing price of Issuer?s common shares.
In March 2006, the Board of Directors approved a plan to raise additional capital from the holders of its outstanding warrants and stock options at a reduced price of $0.04 per share, in order to a) prevent further dilution by the issuance of additional securities to outsiders, and (b) to restructure the capitalization of the Company. On May 1, 2006, the reporting person converted the Series F preferred stock and Series G preferred stock into common shares, and exercised the Series F, Series G and May 23, 2003 warrants for shares of the issuer?s common stock, at an adjusted warrant exercise price of $0.04, to acquire a total of 15,000,000 shares of the company?s common stock.
Resulting purchase from cash dividends paid to Series G preferred stockholders; purchase price based on May 1, 2006 closing price of Issuer?s common shares.
Shares of common stock issued to reporting person in connection with financing costs related to Secured Multi-Draw Term Loan Facility Agreement in the amount of $2,000,000, with a maturity date of January 11, 2010.
Series F private placement consisted of units of Series F preferred shares and Series F warrants at a combined price of $200.01 per unit.
Series G private placement consisted of units of Series G preferred shares and Series G warrants at a combined price of $25,000 per unit.
Warrants acquired as consideration for an amendment to the issuer?s Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person?s ?Facility? to $4,750,000 and extending the maturity date to January 11, 2013.
Warrants acquired as consideration for an amendment to the issuer?s Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person?s ?Facility? to $5,250,000.
Warrants acquired as consideration for an amendment to the issuer?s Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person?s ?Facility? to $5,750,000 and extending the maturity date to January 11, 2016.